David J. Byrne

3.4k total citations
51 papers, 1.2k citations indexed

About

David J. Byrne is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, David J. Byrne has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in David J. Byrne's work include Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Breast Cancer Treatment Studies (7 papers). David J. Byrne is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Breast Cancer Treatment Studies (7 papers). David J. Byrne collaborates with scholars based in Australia, United States and United Kingdom. David J. Byrne's co-authors include Stephen B. Fox, Shona Hendry, Wendy A. Cooper, Gavin Wright, Nicholas Jene, Siddhartha Deb, Sue Sturrock, Kylie L. Gorringe, Elena A. Takano and Adrian L. Harris and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David J. Byrne

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Byrne Australia 20 627 342 333 295 233 51 1.2k
Johanna G. H. van Nes Netherlands 16 681 1.1× 349 1.0× 288 0.9× 182 0.6× 314 1.3× 31 1.2k
Pedro Pérez‐Segura Spain 18 467 0.7× 294 0.9× 407 1.2× 237 0.8× 136 0.6× 117 1.2k
Anupma Nayak United States 20 462 0.7× 379 1.1× 416 1.2× 226 0.8× 147 0.6× 62 1.1k
Chikako Shimizu Japan 17 626 1.0× 484 1.4× 157 0.5× 166 0.6× 144 0.6× 53 975
Marzia Locatelli Italy 17 757 1.2× 535 1.6× 329 1.0× 221 0.7× 151 0.6× 36 1.2k
Zhigang Kang United States 11 483 0.8× 204 0.6× 483 1.5× 303 1.0× 173 0.7× 18 1.1k
Ecaterina E. Dumbrava United States 17 647 1.0× 194 0.6× 379 1.1× 218 0.7× 185 0.8× 115 1.0k
Sumita Trivedi United States 17 843 1.3× 170 0.5× 417 1.3× 289 1.0× 583 2.5× 33 1.5k
Olaf Neumann Germany 15 493 0.8× 483 1.4× 492 1.5× 355 1.2× 84 0.4× 38 1.1k
Jennifer L. Santos Canada 13 416 0.7× 527 1.5× 809 2.4× 172 0.6× 222 1.0× 21 2.0k

Countries citing papers authored by David J. Byrne

Since Specialization
Citations

This map shows the geographic impact of David J. Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Byrne more than expected).

Fields of papers citing papers by David J. Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Byrne. The network helps show where David J. Byrne may publish in the future.

Co-authorship network of co-authors of David J. Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Byrne. A scholar is included among the top collaborators of David J. Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Byrne. David J. Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekaert, David V., Antonio Caracausi, David J. Byrne, et al.. (2024). The low primordial heavy noble gas and 244Pu-derived Xe contents of Earth's convecting mantle. Earth and Planetary Science Letters. 642. 118886–118886. 4 indexed citations
2.
Pang, Jia‐Min, David J. Byrne, Alice R.T. Bergin, et al.. (2023). Spatial transcriptomics and the anatomical pathologist: Molecular meets morphology. Histopathology. 84(4). 577–586. 12 indexed citations
3.
Cai, Ling, Luc Girard, Owen W.J. Prall, et al.. (2023). Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical Cancer Research. 30(9). 1846–1858. 28 indexed citations
4.
Nguyen, Phillip, David J. Byrne, Georgina L. Ryland, et al.. (2023). Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia. SHILAP Revista de lepidopterología. 4(4). 1105–1109. 3 indexed citations
5.
Risbridger, Gail P., Laura H. Porter, Joe Jiang Zhu, et al.. (2021). Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer. Journal of the Endocrine Society. 5(Supplement_1). A1029–A1030. 1 indexed citations
6.
Keam, Simon P., Heloise M. Halse, Thu Quynh Nguyen, et al.. (2020). High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot. Journal for ImmunoTherapy of Cancer. 8(1). e000792–e000792. 51 indexed citations
7.
McEvoy, Christopher R., Holly Holliday, Niko Thio, et al.. (2020). A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors. Laboratory Investigation. 101(1). 26–37. 16 indexed citations
8.
Williams, Scott, Han Xian Aw Yeang, Catherine Mitchell, et al.. (2020). Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report. BMC Urology. 20(1). 171–171. 9 indexed citations
9.
Millen, Rosemary, Shona Hendry, Vignesh Narasimhan, et al.. (2020). CD8+ tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival. Clinical & Translational Immunology. 9(7). e1155–e1155. 6 indexed citations
10.
Byrne, David J., Peter Button, Sunil R. Lakhani, et al.. (2020). 297P SP142 immunohistochemistry (IHC) PD-L1 inter- and intra-pathologist agreement in triple negative breast carcinoma (TNBC). Annals of Oncology. 31. S361–S361. 1 indexed citations
11.
Luen, Stephen J., Huiling Xu, David J. Byrne, et al.. (2020). Using Genomic Sequencing to Explain an Exceptional Response to Therapy in a Malignant Phyllodes Tumor. JCO Precision Oncology. 4(4). 1263–1266. 2 indexed citations
12.
Prall, Owen W.J., Christopher R. McEvoy, David J. Byrne, et al.. (2020). A Malignant Neoplasm From the Jejunum With a MALAT1-GLI1 Fusion and 26-Year Survival History. International Journal of Surgical Pathology. 28(5). 553–562. 30 indexed citations
13.
Karnezis, Tara, Rae H. Farnsworth, Nicole C. Harris, et al.. (2019). CCL27/CCL28–CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells. Cancer Research. 79(7). 1558–1572. 39 indexed citations
14.
Li, Na, Simone McInerny, Magnus Zethoven, et al.. (2019). Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer. JNCI Journal of the National Cancer Institute. 111(12). 1332–1338. 23 indexed citations
15.
Kader, Tanjina, Prue Hill, Magnus Zethoven, et al.. (2019). Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma. The Journal of Pathology. 248(3). 326–338. 21 indexed citations
16.
Hendry, Shona, Jia‐Min Pang, David J. Byrne, et al.. (2017). Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features. Clinical Cancer Research. 23(17). 5210–5217. 57 indexed citations
17.
Deb, Siddhartha, Kylie L. Gorringe, Jia‐Min Pang, et al.. (2017). BRCA2 carriers with male breast cancer show elevated tumour methylation. BMC Cancer. 17(1). 641–641. 10 indexed citations
18.
Pang, Jia‐Min, Siddhartha Deb, Elena A. Takano, et al.. (2014). Methylation profiling of ductal carcinoma in situand its relationship to histopathological features. Breast Cancer Research. 16(5). 423–423. 16 indexed citations
19.
O’Donoghue, Tom & David J. Byrne. (2014). Historical Inquiry into the Construction of Religion as a School Subject for Catholic Schools in Australia. UWA Profiles and Research Repository (University of Western Australia). 1(1). 1–16. 2 indexed citations
20.
Deb, Siddhartha, Ida Johansson, David J. Byrne, et al.. (2014). Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer. Modern Pathology. 27(9). 1223–1230. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna G. H. van Nes Breakdown of academic impact, for papers by Pedro Pérez‐Segura Breakdown of academic impact, for papers by Anupma Nayak Breakdown of academic impact, for papers by Chikako Shimizu Breakdown of academic impact, for papers by Marzia Locatelli Breakdown of academic impact, for papers by Zhigang Kang Breakdown of academic impact, for papers by Ecaterina E. Dumbrava Breakdown of academic impact, for papers by Sumita Trivedi Breakdown of academic impact, for papers by Olaf Neumann Breakdown of academic impact, for papers by Jennifer L. Santos
Rankless by CCL
2026